Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
The nutricosmetics market value is poised to cross $13.7B by 2030, according to a new research report by Global Market Insights. The nutricosmetics Industry is anticipated to register 8.1% CAGR between 2022 and 2030 due to increasing hair and skin care problems and rising awareness of health management.
read more
Lumicera Health Services announced that it will be offering abiraterone acetate 250 mg tablets – the first generic drug made by CivicaScript™.
read more
Tris Pharma announced that DYANAVEL® XR (amphetamine) extended-release tablets, for oral use, CII are now available in pharmacies. DYANAVEL XR was approved by the U.S. Food and Drug Administration for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older.
read more
The potential growth difference for the nutritional supplements market between 2020 and 2025 is $27.67B, as per the latest market analysis report by Technavio. The report predicts the market to witness an accelerating growth momentum at a CAGR of 4%.
read more
Novadoz Pharmaceuticals will manufacture several new products, including:
Pirfenidone 267 mg and 801 mg tablets (AB rated to Esbriet),
Chlorpromazine 25 mg, 50 mg, 100 mg and 200 mg tablets (AB rated to Thorazine)
Bortezomib 3.5 mg vials (AP rated to Velcade)
Bumetanide 4 mL SDV and 10 mL MDV (0.25 mg/mL) (AP rated to Bumex)
read more
The global herbal medicine market size was worth around $166B in 2021 and is predicted to grow to around $348B by 2028 with a compound annual growth rate (CAGR) of roughly 11.2% between 2022 and 2028, according to a Zion Market Research study.
read more
Tris Pharma announced the decision by the US District Court for the District of New Jersey to uphold the validity of various patents relating to QuilliChew ER® (methylphenidate hydrochloride) extended-release chewable tablets, for oral use.
read more
The global medical marijuana market size was valued at $11.70B in 2021 and is likely to reach value of $40.02B by 2028; it is estimated to grow at a CAGR of 19.2% from 2022 to 2028, according to a report by The Insight Partners.
read more
Global dietary supplements market will project a CAGR of 8.72% for the forecast period of 2022-2029, according to a study by Data Bridge Market Research.
read more
The growing obese population is predicted to boost demand for weight loss supplements as these are widely adopted by individuals as healthy options to reduce weight. For instance, according to the World Health Organization (WHO), over 1 billion people globally are obese currently (2022).
read more
Alpha Cognition, a biopharmaceutical company, announced positive results from a bioequivalence study with ALPHA-1062, a proprietary, delayed release oral tablet formulation in development for the treatment of mild to moderate Alzheimer’s Disease (AD).
read more
ACG, an integrated pharmaceutical and nutraceutical manufacturing company, will launch a process lab in Germany in 2023.
read more
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA® (ibrutinib) for the treatment of pediatric patients one year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.
read more
The global active pharmaceutical ingredients (API) market size reached$209.9B in 2021, according to a report from Research & markets. Looking forward, the publisher expects the market to reach$291.7B by 2027, exhibiting a CAGR of 5.64% during 2021-2027.
read more
Lysulin, a blood sugar supplement, is now available in the U.S.
Clinical studies show Lysine and Vitamin C help maintain healthy blood sugar levels, according to the company. Millions of people have excess sugar in their bloodstream, which can have adverse effects on the body's organs.
read more